About IPC Interactive Meet

India enjoys an important position in the global pharmaceuticals sector. The country also has a largepool of scientists and engineers who have the potential to steer the industry ahead to an even higherlevel. Based on continued needs and strong stakeholder feedback, we are organizing “1st IPCInteractive Meet on Pharmacopoeia Standards: Regulatory and Quality Considerations” on February 4,2019 at Institute of Microbial Technology (IMTECH), Chandigarh. This meet would provide a platformand unique opportunity for interaction between industry, academia, regulatory bodies and subjectexperts of the field of pharmaceutical analysis, pharmacopoeial sciences and their correlation withregulatory mechanisms. This interactive meet is expected to:

  • Create awareness about setting the IP standards among the stakeholders
  • Understand and resolve the issues related to compliance of pharmacopoeia standards
  • Deliberate on the issues of monograph modernization and harmonization
  • Better understand regulatory pathways for the approval of drugs in India
  • Provide common platform for regulatory understanding between regulatory bodies, IPC andindustry

About IPC

Indian Pharmacopoeia Commission (IPC) is an autonomous Institution of the Ministry of Health andFamily Welfare, Government of India to set standards of drugs in the country with a vision ‘to promotethe highest standards of drugs for use in human and animals’ and mission ‘to promote public health inIndia by bringing out authoritative and officially accepted standard for quality of drugs’. It has basicfunction to update regularly the standards of drugs by publishing official written standard in the formof Indian Pharmacopoeia (IP). IPC also provides measurement standards in the form of IPRS which actas a finger print for identification of an article under test and its purity as prescribed in IP.

Indian Pharmacopoeia

Indian Pharmacopoeia (IP) is the official book of standards of medicines being manufactured and/ormarketed in India. IP contains collection of authoritative procedures of analysis of drugs with specifiedlimits. IP prescribes standards for identity, purity, safety and strength of drugs both for human andanimals. The IP, or any part of it, has got legal status under the Second Schedule of the Drugs &Cosmetics Act, 1940 and Rules 1945 there under. IP standards are authoritative in nature and areenforced by the regulatory authorities for quality control of medicines in India. During qualityassurance and at the time of dispute in the court of law the IP standards are legally acceptable.

Target Audience

  • QC Analysts of Manufacturing and Regulatory Laboratories
  • R&D Scientists of Manufacturing and Academic Labs
  • Regulatory Affairs Professionals
  • Contract Research Organization Scientists & Managers
  • Contract Manufacturing Organizations Professionals

Registrations

Please Click here to download the registration form

registrations.JPG

*No refunds will be issued for any cancellation requests or failure to attend the workshop. However, wemay consider request for substitute registrant from the same organization.

*Submit the filled application form to the undersigned. 

Registration Enquiries

Dr. Pawan K. Saini/ Dr. Gaurav Pratap Singh
Email: ipclab@vsnl.net, tsectipc@gmail.com
Phone: +91-120-2783400, 2783401, +91-9968103183 (M)
Website: www.ipc.gov.in

Program Schedule

schedule.jpg